Albert et al developed a nomogram for an older woman with breast cancer undergoing conservative surgical resection. This can help to determine if radiation therapy is likely to benefit the patient. The authors are from the University of Texas M.D. Anderson Cancer Center and the University of Chicago.
Patient selection: age 66 to 79 with favorable breast cancer treated conservatively
Parameters:
(1) age in years
(2) race
(3) tumor diameter in cm
(4) estrogen receptor (ER) status
(5) lymph node status and radiation therapy
Parameter |
Finding |
Points |
---|---|---|
age in years |
66 to 69 years |
20 |
|
70 to 74 years |
26 |
|
75 to 79 years |
0 |
race |
white |
16.7 |
|
black |
42.2 |
|
other |
0 |
tumor size |
<= 2.0 cm |
0 |
|
> 2 cm |
15.5 |
er status |
positive |
0 |
|
borderline |
50 |
|
negative |
50 |
lymph node status and radiation |
clinically negative and no radiation |
88.7 |
|
clinically negative and radiation |
0 |
|
pathologically negative and no radiation |
67.7 |
|
pathologically negative and radiation |
23.3 |
|
pathologically positive and no radiation |
100 |
|
pathologically positive and radiation therapy |
26.4 |
total score =
= SUM(points for all 5 parameters)
Interpretation:
• minimum score: 0
• maximum score: 234
• The higher the score the worse the mastectomy-free survival (MFS).
Score |
5-year MFS survival |
---|---|
< 35 |
> 99% |
35 to 131 |
100.2 – (0.03143 * (score)) |
131 to 234 |
(-0.001156 * ((score)^2)) + (0.2171 * (score)) + 87.11 |
Score |
10-year MFS survival |
---|---|
< 78 |
> 95% |
78 to 234 |
(-0.001767 * ((score)^2)) + (0.256 * (score)) + 85.5 |
Specialty: Hematology Oncology, Surgery, general, Obstetrics & Gynecology